Is combining vascepa with antioxidants recommended?

Is combining Vascepa with antioxidants recommended?

Vascepa is a prescription medication containing icosapent ethyl, a highly purified form of eicosapentaenoic acid (EPA). It is used to reduce cardiovascular risk in patients with high triglycerides or in those already on statin therapy.

How does Vascepa interact with antioxidants?

Vascepa works primarily through EPA's anti-inflammatory and plaque-stabilizing effects. Antioxidants such as vitamin E, vitamin C, or coenzyme Q10 may complement these actions by reducing oxidative stress, which is a factor in cardiovascular disease. Some studies suggest that antioxidants can stabilize EPA against oxidation in vitro, but clinical evidence for specific interactions is limited.

What happens if you combine Vascepa with antioxidants?

No major interactions between Vascepa and common antioxidants are reported in prescribing information or interaction databases. Combining them is generally considered safe at standard doses. The manufacturer does not prohibit their use together, but does not provide guidance on optimal pairing.

When does Vascepa patent expire?

Vascepa's primary composition-of-matter patent expired in 2020. Secondary patents covering formulation and use are scheduled to expire in 2030 and 2033. [1]